Jiksak Bioengineering Competitors and Similar CompaniesClear all
Jiksak Bioengineering's competitors and similar companies include Hopstem Biotechnology, Asceneuron and Neuraly.
 Jiksak Bioengineering Jiksak Bioengineering is a biotechnology company developing nerve tissue products for neurodegenerative diseases. |  Hopstem Biotechnology Hopstem Biotechnology (霍德生物) is a company committed to producing neural stem cell products for CNS drug screening and toxicity evaluation, as well as clinical cell therapy and regeneration medicine. |  Neuraly Neuraly is a clinical-stage biotechnology company that specializes in the development of drugs for neurodegenerative diseases. | ||
Founding Date | Founding Date 2017 | Founding Date 2017 | Founding Date 2012 | Founding Date 2016 |
Type | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Kawasaki, JP HQ | Locations Hangzhou Shi, CN HQ Houston, US | Locations Lausanne, CH HQ | Locations Gaithersburg, US HQ |
Employees | Employees 4 | Employees 614% decrease | Employees 166% decrease | Employees 186% increase |
Funding | ||||
Latest funding round | Latest funding round $ 1.8m (over 8 years ago) | Latest funding round $ 1.7m (about 9 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.8m | Total funding raised $ 1.7m | Total funding raised N/A | Total funding raised $ 36m |
For sources of this data, please see the company profile
View Company Profiles
Hopstem Biotechnology
HQ
Hangzhou Shi, CN
Employees
6↓ 14% decrease
Hopstem Biotechnology (霍德生物) is a company committed to producing neural stem cell products for CNS drug screening and toxicity evaluation, as well as clinical cell therapy and regeneration medicine.
View company
Asceneuron
HQ
Lausanne, CH
Employees
16↓ 6% decrease
Asceneuron is a clinical stage biotech company focusing on neurodegenerative disorders.
View companyNeuraly
HQ
Gaithersburg, US
Neuraly is a clinical-stage biotechnology company that specializes in the development of drugs for neurodegenerative diseases.
View company